Developing Compelling Global Health Policy Narratives and Supporting Evidence

As a part of its global therapeutic area (TA) health policy initiatives, a leading biopharma company needed a new and improved narrative and evidence deck to impress upon policymakers and other critical stakeholders the importance of timely diagnosis and treatment of a specific disease. The materials were structured in three sections:

  1. Making the case for change for policy makers
  2. Giving reasons to believe effective policy solutions are available
  3. Issuing a call to action by policy makers

BTG delivered a senior health policy consultant to analyze the current research and materials to better understand the burden and impact of the disease. The consultant then created a TA-specific health policy narrative for both U.S. and ex-U.S. markets, developed a one-page leave-behind tailored to each market, and built an external evidence deck for presentation at regional franchise meetings.

 

Previous Article
Niche Knowledge and Experience with Regulatory Agencies
Niche Knowledge and Experience with Regulatory Agencies

In response to soaring demand for disinfectants, a global consumer goods company wanted to focus on develop...

Next Article
A Rare Disease Specialist Fluent in the Project Location’s Language
A Rare Disease Specialist Fluent in the Project Location’s Language

In an effort to inform its Rare Diseases commercial strategy within a specific country, an F100 pharmaceuti...

×

Talk with BTG to learn more about our on-demand talent.

First Name
Last Name
Company
Country
I would like to receive the latest expert insights and news from Business Talent Group.
By registering, you agree to the processing of your personal data by Business Talent Group as described in the Privacy Statement.
View our Privacy Policy and Cookie Policy
Thank you! We will be in touch shortly.
Error - something went wrong!